Extendicare Inc. (TSE:EXE - Get Free Report) shares crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$9.10 and traded as high as C$10.24. Extendicare shares last traded at C$10.23, with a volume of 49,843 shares.
Analyst Ratings Changes
Several brokerages recently weighed in on EXE. TD Securities boosted their target price on shares of Extendicare from C$9.50 to C$10.50 and gave the company a "hold" rating in a research note on Thursday, November 14th. Royal Bank of Canada upped their price target on Extendicare from C$9.50 to C$11.00 and gave the stock a "sector perform" rating in a report on Thursday, November 28th.
Read Our Latest Analysis on EXE
Extendicare Trading Up 0.5 %
The company has a current ratio of 0.60, a quick ratio of 0.98 and a debt-to-equity ratio of 305.80. The company's fifty day moving average is C$10.34 and its 200-day moving average is C$9.10. The firm has a market capitalization of C$853.90 million, a P/E ratio of 15.04 and a beta of 1.26.
Extendicare (TSE:EXE - Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported C$0.19 earnings per share (EPS) for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. During the same quarter in the previous year, the company posted $0.13 earnings per share. As a group, sell-side analysts anticipate that Extendicare Inc. will post 0.6134729 earnings per share for the current fiscal year.
Extendicare Dividend Announcement
The firm also recently disclosed a monthly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, February 14th will be given a $0.04 dividend. The ex-dividend date is Friday, January 31st. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.69%. Extendicare's payout ratio is 70.59%.
Extendicare Company Profile
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Read More
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
